Serum Laminin P1 as an Indicator in Small Cell Lung Cancer
Author Information
Author(s): T. Nakano, N. Iwahashi, J. Maeda, T. Hada, K. Higashino
Primary Institution: Hyogo College of Medicine
Hypothesis
SCLC may be associated with elevated laminin P1 levels by production of laminin or increased degradation of basement membrane.
Conclusion
Serum laminin P1 levels are significantly higher in small cell lung cancer patients compared to those with non-small cell lung cancer, respiratory infections, and normal subjects, but do not correlate with the extent of disease.
Supporting Evidence
- 58.9% of SCLC patients had elevated serum laminin P1 levels.
- Median serum laminin P1 levels in SCLC were significantly higher than in NSCLC, respiratory infections, and normal subjects.
- Serum laminin P1 levels did not correlate with the extent of disease in SCLC.
Takeaway
Doctors found that a substance called laminin P1 is higher in people with a type of lung cancer called small cell lung cancer, which might help in diagnosing it.
Methodology
The study included 17 SCLC patients, 26 NSCLC patients, 11 with respiratory infections, 7 with pulmonary fibrosis, and 10 normal subjects, measuring serum laminin P1 levels using a radioimmunoassay.
Limitations
The study did not establish a correlation between laminin P1 levels and the clinical stage of SCLC.
Participant Demographics
Patients included 17 with SCLC, 26 with NSCLC (14 adenocarcinomas, 8 squamous cell carcinomas, 4 large cell carcinomas), 11 with respiratory infections, 7 with pulmonary fibrosis, and 10 normal subjects.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website